摘要
对９０例白血病及３８例ＭＤＳ患者和４０例正常人的血清β２微球蛋白（Ｂ２Ｍ）进行了测定，结果显示了白血病患者特别是急性淋巴细胞性白血病患者血清β２Ｍ值显著高于正常对照组（Ｐ＜０．０５），动态观察了β２Ｍ的变化与患者分型、病情、疗效及预后的关系。提出了β２Ｍ测定有利于对白血病患者缓解率、缓解时间及预后的正确估价。
The Lever of Serum β2-Microglobulin(β2M)were derterminated in 128 patients with Leukemia. Myelodysplastic Syndrome(MDS)and 40 normal adutts. It was showed that the lever of β2M was markedly higher(P<0.05) inleukemia,especialy in paticent with acute lymphocytic leukemia(ALL).The results also showed that dynamic observeration of the β2M lever might be useful in evaluating the therpy reaction and prognosis in patients with leukemia
出处
《临床血液学杂志》
1995年第4期159-161,共3页
Journal of Clinical Hematology
关键词
微球蛋白
白血病
预后
β_2-Microglobulin Leukemia,clinical significance
